Impact of Sacubitril/Valsartan Versus Ramipril on Total Heart Failure Events in the PARADISE-MI Trial

Marc A Pfeffer, Brian Claggett, Eldrin F Lewis, Christopher B Granger, Lars Køber, Aldo P Maggioni, Douglas L Mann, John J V McMurray, Jean-Lucien Rouleau, Scott D Solomon, Philippe Gabriel Steg, Otavio Berwanger, Maja Cikes, Carmine G De Pasquale, Alberto Fernandez, Gerasimos Filippatos, Karola Jering, Ulf Landmesser, Venugopal Menon, Béla MerkelyMark C Petrie, Ivo Petrov, Morten Schou, Michele Senni, David Sim, Peter van der Meer, Martin Lefkowitz, Yinong Zhou, Yi Wang, Eugene Braunwald

33 Citations (Scopus)
Original languageEnglish
JournalCirculation
Volume145
Issue number1
Pages (from-to)87-89
Number of pages3
ISSN0009-7322
DOIs
Publication statusPublished - 4 Jan 2022

Keywords

  • heart failure
  • myocardial infarction
  • ramipril
  • sacubitril/valsartan
  • Heart Failure/drug therapy
  • Ramipril/pharmacology
  • Valsartan/pharmacology
  • Humans
  • Aminobutyrates/pharmacology
  • Antihypertensive Agents/pharmacology
  • Biphenyl Compounds/pharmacology
  • Drug Combinations

Cite this